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ABSTRACT 
Objective: The objective of the current study was to develop and validate the RP-HPLC method for the simultaneous estimation of Tramadol 
Hydrochloride, Chlorzoxazone and Diclofenac sodium from their combined tablet dosage form 
Methods: The current method describes RP-HPLC method for the estimation of Tramadol Hydrochloride, Chlorzoxazone and Diclofenac sodium 
from their combined tablet dosage form. The mobile phase used was Acetonitrile: 0.05M Disodium Hydrogen Phosphate buffer pH 3.5 adjusted with 
10% v/v Ortho Phosphoric acid(50:50 v/v) and Hypersil ODS C18
Keywords: Diclofenac sodium, Tramadol Hydrochloride, Chlorzoxazone, RP-HPLC method, Analytical method validation. 
 (250 mm x 4.6 mm, 5.0 μ particle sizes) was used as a stationary phase with 
detection wavelength of 220 nm.  
Result: Linearity was obtained in the concentration range of 15-75 μg/ml, 100-500 μg/ml and 20-100 μg/ml for TRM, CHL and DIC respectively. 
The % recovery was found to be 99.41 -99.84%, 99.30 - 99.74 % and 99.6 - 99.97 % for DIC, TRM and CHL respectively. The LOQ was found to be 
3.33, 3.95 and 36.71 μg/ml for DIC, TRM and CHL respectively. The proposed method has been validated as per ICH Q2R1 guidelines and 
successfully applied to the estimation of TRM, DIC and CHL from their combined Tablet dosage form. 
Conclusion: The method was found to be simple, accurate, precise, and suitable for the estimation of Tramadol Hydrochloride, Chlorzoxazone and 
Dicofenac sodium from their combined tablet dosage form. 
 
INTRODUCTION 
Tramadol Hydrochloride (TRM) is chemically (lRS,2RS)-2-
[(dimethyl amino) methyl]-I-(3-methoxyphenyl) cyclohexanol 
hydrochloride [1] (Figure 1). TRM belongs to analgesic and narcotic 
category. TRA and its O-desmethyl metabolite (M1) are selective, 
weak OP3-receptor agonists. It is indicated in the treatment of 
moderate to severe pain. TRM is used to treat postoperative, dental, 
cancer, and acute musculosketetal pain and as an adjuvant to NSAID 
therapy in patients with osteoarthritis. Tramadol Hydrochloride is 
official in Indian Pharmacopoeia [1], British Pharmacopoeia [2] and 
United States Pharmacopoeia[3]. 
Diclofenac sodium (DIC) is chemically Sodium 2-[(2,6-
dichlorophenyl)amino] phenyl acetate[4] (Figure 2). DIC is used in 
acute and chronic treatment of signs and symptoms of osteoarthritis 
and rheumatoid arthritis. Diclofenac sodium is official in Indian 
Pharmacopoeia[4], British Pharmacopoeia[5] and United States 
Pharmacopoeia[6]. Chlorzoxazone (CHL) is chemically 2(3H)-
Benzoxazolone, 5-Chloro-2-benzoxazolinone[6] (Figure 3). It is 
indicated for the relief of discomfort associated with acute painful 
musculoskeletal conditions. Chlorzoxazone is official in United 
States Pharmacopoeia [6]. The review of literature revealed that 
many analytical methods involving UV Spectrophotometric [7-8], 
RP-HPLC[9-11], HPTLC[12] and UPLC[13] have been reported for 
TRM individually and in combination with other drugs. Several 
methods have been reported for the estimation of DIC individually and 
in combination with other drugs such as UV Spectrophotometric[14], 
RP-HPLC[15-17], HPTLC[18] and LC-MS[19]. Several methods have been 
reported for Chlorzoxazone individually and in combination with other 
drugs namely UV Spectrophotometric[20], RP-HPLC[21] and HPTLC[22]. 
But no method has been reported for the estimation of TRM, DIC and 
CHL from their combined dosage form. 
So, the present article describes RP-HPLC method for the estimation 
of TRM, DIC and CHL in their tablet dosage form. The developed 
method was validated applying ICH Q2R1 guidelines[23] and was 
used for the assay of three drugs in their tablet dosage form. 
 
 
Fig. 1: It shows the chemical structure of Tramadol 
Hydrochloride 
 
Fig. 2: It shows the chemical structure of Diclofenac Sodium 
 
 
Fig. 3: It shows the chemical structure of Chlorzoxazone 
 
MATERIALS AND METHODS 
Materials 
Analytically pure samples of TRM, DIC and CHL were procured from 
Medico Lab, Vatva, Ahmedabad; Medico Lab, Vatva, Ahmedabad and 
Baroque Pharmaceuticals ltd., Khambhat respectively.  
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Orthophosphoric acid (A.R. Grade) was purchased fromSD Fines 
chemicals, Bombay; Water (HPLC Grade) from RFCL limited, New 
Delhi; Acetonitrile (HPLC Grade) from RFCL limited, New Delhi and 
Disodium Hydrogen Phosphate (A. R. Grade) from SD Fines 
chemicals, Bombay. Tablet of TRM, DIC and CHL in combined dosage 
form (TRICARE-MR) was purchased from the local market. 
Instrument and experimental condition 
RP-HPLC analysis was carried out on the instrument of Analytical 
Technologies limited with the injector loop of 20 µl on the isocratic 
mode. The pump used was P2230 plus HPLC pump and the detector 
UV 2230 plus detector.  
The data was analyzed using Analchrom 2006 software. The column 
used was Hypersil ODS C18
Preparation of Mobile Phase 
 (250 × 4.6 m, 5 µm particle size). The pH 
meter used was Chemiline Digital pH meter CL-110. 
Accurately measured 7.089 gm Disodium Hydrogen Phosphate was 
dissolved in 1000 ml of HPLC grade water. A mixture of 50 ml 
Acetonitrile and 50 ml of 0.05M Disodium Hydrogen phosphate was 
prepared and the pH of the mixture was adjusted to 3.5 pH with 10 
% orthophosphoric Acid and sonicated for 10 minutes, filtered 
through 0.45 μm filter paper and sonicated for 10 minutes to degas 
the mixture and used as mobile phase. 
Preparation of standard stock solution 
A 100 mg of standard TRM, DIC and CHL were accurately weighed 
and transferred to each of 100 ml volumetric flask and dissolved in 
50 ml methanol. The flask was sonicated for 10 min. The flask was 
shaken and volume was made up to the mark with methanol to give 
solutions containing 1000 μg/ml TRM, DIC and CHL. 
Analytical Method validation 
(1) Linearity and Range 
The linearity of analytical method is its ability to elicit test results 
that are directly proportional to the concentration of analyte in 
sample within a given range. The range of analytical method is the 
interval between the upper and lower levels of analyte that have 
been demonstrated to be determined within a suitable level of 
precision, accuracy and linearity.  
The range were found to be 20-100 μg/ml for DIC, 15-75 μg/ml for 
TRM and 100-500 μg/ml for CHL. All the chromatogram was 
repeated for 6 times. Calibration curves were constructed by 
plotting average Area versus concentrations for all the three drugs. 
Straight line equations were obtained from these calibration curves.  
(2) Repeatability  
Standard solution mixture containing TRM (15-75 μg/ml), DIC (20-
100 μg/ml) and CHL (100-500 μg/ml) were prepared and 
chromatograms were recorded and area were measured and C.V. 
were calculated. Sample solution containing 30 μg/ml TRM, 40 
μg/ml DIC and 200 μg/ml CHL was prepared and chromatogram 
was recorded. Area was measured of the same concentration 
solution six times and CV was calculated.  
(3) Precision (Inter-day and Intra-day) 
The precision of an analytical method is the degree of agreement 
among individual test results when the method is applied repeatedly 
to multiple samplings of homogenous samples. It provides an 
indication of random error results and was expressed as Coefficient 
of Variance (CV).  
Variations of results within the same day (intra-day), variation of 
results between days (inter-day) were analyzed. Intraday precision 
was determined by analyzing TRM, DIC and CHL for three times in 
the same day. Inter day precision was determined by analyzing the 
three drugs daily for three days. For this study standard solution 
mixture of 15, 45 and 75 μg/ml for TRM; 20, 60 and 100 μg/ml for 
DIC and 100, 300, 500 μg/ml for CHL were prepared and 
chromatograms were recorded.  
(4) Accuracy  
Accuracy is the closeness of the test results obtained by the method 
to the true value. To study the accuracy sample solution of 
formulation was prepared and analysis of the same was carried out. 
Recovery studies were carried out by addition of standard drug to 
the sample solution at 3 different concentration levels 50, 100 and 
150 %, taking into consideration percentage purity of added bulk 
drug samples. Each concentration was analyzed three times and 
average recoveries were measured. 
(5) Reproducibility 
The areas were measured using same instrument by twoanalysts for 
sample solution and the values obtained were evaluated using t-test 
to verify their reproducibility.  
(6) Specificity and Selectivity 
Specificity is a procedure to detect quantitatively the analyte inthe 
presence of component that may be expected to be present in the 
sample matrix, while selectivity is the procedure to detect 
qualitatively the analyte in presence of components that may be 
expected to be present in the sample matrix. Specificity of an 
analytical method is ability to measure specifically the analyte of 
interest without interferences from blank and placebo. It was 
checked for interference from blank.  
(7) Limit of detection & Limit of quantification 
The limit of detection (LOD) and the limit of quantification (LOQ) of 
the drug were derived by using the following equations as per 
International Conference on Harmonization (ICH) guidelines which 
is based on the calibration curve.  
LOD = 3.3 × σ /S  
LOQ = 10 × σ /S  
Where σ = the standard deviation of y-intercepts of regression lines  
S = Slope of calibration curve.  
(8) Assay of marketed formulation 
Twenty tablets were weighed individually and the average weight of 
the single tablet was found to be 752 mg. Powder equivalents to 250 
mg CHL, 50 mg DIC and 37.5 mg TRM was accurately weighed and 
transferred to 25 ml volumetric flask. 15 ml of methanol was added 
to same volumetric flask and sonicated for 20 min. The flask was 
shaken and volume was made up to the mark with methanol. The 
above solution was filtered through whatmann filter paper 
(0.45μm). 5 ml of aliquot was taken and transferred to volumetric 
flask of 50 ml capacity and volume was made up to the mark with 
the methanol. Further 2 ml of this solution was transferred to 
volumetric flask of 10 ml capacity. Volume was made up to the mark 
with the mobile phase to give a solution containing 30 μg/ml TRM, 
40 μg/ml DIC and 200 μg/ml CHL. This solution was sonicated for 5 
min. This solution was used for the estimation of TRM, DIC and CHL. 
RESULTS AND DISCUSSION 
Method optimization 
For the selection of mobile phase, various mobile phase systems 
were tried for thechromatographic separation.Finally, the system 
containing Acetonitrile and 0.05M Disodium Hydrogen phosphate 
with a pH 3.5 adjusted with 10 % Ortho Phosphoric Acid (50:50 
%v/v) gave well resolved peaks of all the three drugs. The average 
retention time of TRM, CHL and DIC were found to be 2.11 min., 3.82 
min. and 12.39 min. respectively. For the selection of analytical 
wavelength, the overlain spectra of 50 μg/ml TRM, 50 μg/ml DIC 
and 50 μg/ml CHL revealed that at 220 nm all the three drugs 
possess absorbance (Fig. 4).  
Analytical method validation 
1) Linearity and Range 
The method was found to be linear at the concentration range of 15-
75 µg/ml for TRM, 100-500 µg/ml for CHL and 20-100 µg/ml for 
DIC.  
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Calibration data for TRM, CHL and DIC are shown in Table 2-4 
respectively. The calibration curves for TRM, DIC and CHL were 
prepared by plotting area and concentration(Fig. 6-8). 
 
Fig. 4: It shows the overlain spectra of 50 μg/ml TRM, 50 μg/ml 
DIC and 50 μg/ml CHL in Methanol 
 
 
Fig. 5: It shows the chromatogram of mixed standard solution 
containing 60 μg/ml TRM, 400 μg/ml CHL and 80 μg/ml DIC, 
using mobile phase Acetonitrile: 0.05M Disodium Hydrogen 
Phosphate buffer pH 3.5 (50:50 v/v) (Proposed Method).
 
Table 1: It shows the optimized Chromatographic conditions for TRM, CHL and DIC 
Parameter  Conditions  
Mobile phase  Acetonitrile: 0.05M Disodium Hydrogen Phosphate buffer pH 3.5 adjusted with 10 % Ortho Phosphoric acid 
Pump Mode  Isocratic  
Column  Hypersil ODS C18
Detection wavelength (nm)  
, 250 x 4.6 mm (5 μm)  
220  
Flow rate  1.5 ml/min  
Run Time ( min)  20.0  
Diluent  Mobile phase 
Volume of Injection (μl)  20.0  
Retention time  TRM: 2.11 min 
CHL: 3.82 min  
DIC: 12.39 min  
 
Table 2: It shows the result of calibration readings for TRM by HPLC method 
Concentration (µg/ml) Area Mean ± S.D. C.V 
15 109.16 ± 1.4454 1.32 
30 231.05 ± 2.1030 0.91 
45 353.11 ± 3.9710 1.12 
60 476.16 ± 4.3070 0.90 
75 568.97 ± 4.4632 0.78 
 
 
Fig. 6: It shows the calibration curve of TRM by RP-HPLC 
method. 
 
Table 3: It shows the result of calibration readings for CHL by 
HPLC method 
Concentration (µg/ml) Area Mean ± S.D. C.V 
100 1340.11 ± 14.8804 1.11 
200 2827.63 ± 21.1644 0.74 
300 4278.32 ± 29.2475 0.68 
400 6243.63 ± 60.5147 0.97 
500 7968.69 ± 87.2778 1.09 
 
Fig. 7: It shows calibration curve of CHL by RP-HPLC method 
 
Table 4: It shows the result of calibration readings for DIC by 
HPLC method 
Concentration (µg/ml) Area Mean ± S.D. C.V 
20 174.065 ± 2.0449 1.17 
40 601.018 ± 5.9305 0.98 
60 926.337 ± 8.8130 0.95 
80 1242.75 ± 9.9257 0.79 
100 1547.98 ± 13.402 0.86 
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Fig. 8: It shows calibration curve of DIC by RP-HPLC method 
 
2) Repeatability: 
The developed method was found to be repeatable since C.V. was 
found to be less than 2 for all the drugs. 
3)Limit of Detection (LOD) and Limit of Quantitation (LOQ) 
The LOD for TRM, DIC and CHL was found to be 1.30 μg/ml, 1.10 
μg/ml and 12.11 μg/ml respectively. The LOQ for TRM, DIC and CHL 
was found to be 3.95 μg/ml, 3.33 μg/ml and 36.71 μg/ml 
respectively 
4) Accuracy 
Accuracy was determined by calculating the % recovery. The method 
was found to be accurate with % recovery 99.30 - 99.74 % for TRM, 
99.41 – 99.84% for DIC and 99.6 - 99.97 % for CHL (Table 5). 
5) Precision 
Precision was calculated as repeatability and intra- and inter-day 
variation for all the threedrugs. The method was found to be precise 
with C.V. 0.86 – 0.99 for intra-day (n=3) and C.V. 0.95 – 1.15 for inter-day 
(n=3) for TRM; C.V. 0.77 – 0.97 for intra-day (n=3) and C.V. 0.98 – 1.17 
for inter-day (n=3) for DIC and C.V. 0.69 – 0.97 for intra-day (n=3) and 
C.V. 0.97 – 1.31 for inter-day (n=3) for CHL (Table 6-8).  
  
Table 5: It shows the accuracy studies for TRM, CHL and DIC by HPLC method (n=3) 
% Level of 
Recovery 
Amount of drug in 
sample (µg/ml) 
Amount of standard 
added (µg/ml) 
Total amount of 
Drug (µg/ml) 
Amount of drug recovered 
(µg/ml) ± SD 
% Recovery ± 
SD 
TRM (µg/ml) TRM (µg/ml) TRM (µg/ml) TRM (µg/ml) % TRM 
Unspiked 30 0 30 29.55 ± 0.4574 - 
50 % 30 15 45 14.89 ± 0.1327 99.30 ± 
0.8722 
100 % 30 30 60 29.82 ± 0.1681 99.39 ± 
0.5572 
150 % 30 45 75 44.88 ± 0.1543 99.74 ± 
0.3349 
 DIC (µg/ml) DIC 
(µg/ml) 
DIC (µg/ml) DIC (µg/ml) % DIC 
Unspiked 40 0 40 39.82 ± 0.1541 - 
50 % 40 20 60 19.95 ± 0.0989 99.75 ± 
0.4949 
100 % 40 40 80 39.76 ± 0.1840 99.41 ± 
0.4581 
150 % 40 60 100 59.91 ± 0.0917 99.84 ± 
0.1541 
 CHL (µg/ml) CHL (µg/ml) CHL (µg/ml) CHL (µg/ml) % CHL 
Unspiked 200 0 200 199.31 ± 0.7764 - 
50 % 200 100 300 99.67 ± 0.5800 99.67 ± 
0.5800 
100 % 200 200 400 199.93 ± 0.6759 99.97 ± 
0.3362 
150 % 200 300 500 298.79 ± 0.6308 99.6 ± 0.2118 
 




(Area ± S.D) 
C.V. Inter-day 
(Area ± S.D) 
C.V. 
15 110.1 ± 0.9543 0.86 109.95 ± 1.2744 1.15 
45 352.71 ± 3.3369 0.94 349.71 ± 3.3459 0.95 
75 565.17 ± 5.5827 0.99 567.70 ± 5.6119 0.98 
 




(Area ± S.D) 
C.V. Inter-day 
(Area ± S.D) 
C.V. 
100 1340.13 ± 13.0147 0.97 1342.22 ± 17.6192 1.31 
300 4274.11 ± 37.462 0.87 4258.01 ± 42.0006 0.98 
500 7928.8 ± 55.2941 0.69 7927.32 ± 77.3596 0.97 
 




(Area ± S.D) 
C.V. Inter-day 
(Area ± S.D) 
C.V. 
20 173.55 ± 1.6879 0.97 174.05 ± 2.0439 1.17 
60 926.78 ± 7.2179 0.77 925.53 ± 9.0790 0.98 
100 1538.37 ± 13.8437 0.89 1537.92 ± 16.0222 1.04 
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6) Reproducibility 
The method was found to be reproducible (Table 9-11).  
 
Table 9: It shows the reproducibility data for TRM (30 μg/ml) 
Analyst 1 
Area ± S.D. (n=3) 
Analyst 2 
Area ± S.D. (n=3) 
Result of t test* Inference 
232.79 ± 1.9567 231.64 ± 2.5402 0.341 No significant difference 
 * At 95% confidence interval, (t-Tabulated = 4.30) 
 
Table 10: It shows the reproducibility data for CHL (200 μg/ml) 
Analyst 1 
Area ± S.D. (n=3) 
Analyst 2 
Area ± S.D. (n=3) 
Result of t test* Inference 
2860.9 ± 5.9568 2857.97 ± 4.0887 0.333 No significant difference 
 * At 95% confidence interval, (t-Tabulated = 4.30) 
 
Table 11: It shows the reproducibility data for DIC (40 μg/ml) 
Analyst 1 
Area ± S.D. (n=3) 
Analyst 2 
Area ± S.D. (n=3) 
Result of t test* Inference 
559.72 ± 3.1038 559.21 ± 4.5717 0.923 No significant difference 
* At 95% confidence interval, (t-Tabulated = 4.30) 
7) System suitability parameters 
 






Retention time (min) 12.392 ± 0.3045 3.828 ± 0.0348 2.116 ± 0.0174 - - 
Resolution (Rs) 12.142 ± 0.8527 6.292 ± 0.0591 3.18 ± 0.101 > 2 Criteria met 
Tailing Factor 1.684 ± 
0.1335 
1.3 ± 0.1264 1.38 ± 0.1166 < 2 Criteria met 
Theoretical Plates 
(Plates/Meter) 
8783.42 ± 1409.2 7620.15 ± 228.291 7678.8 ± 261.282 > 2000 Criteria met 
 
Table 13: It shows the assay result of marketed formulation (n=3) 











%Assay ± SD 
Tricare-MR DIC 40 39.95 50 49.9379 99.88 ± 0.2027 
TRM 30 29.91 37.5 37.3833 99.69 ± 0.4573 
CHL 200 199.78 250 249.725 99.89 ± 0.5466 
 
8) Specificity 
The method was found to be specific as no interferencewas 
observed when the chromatogram was recorded in the presence of 
excipients.  
 
Fig. 9: It shows the chromatogram of specificity study. 
9) Assay 
Formulation was analyzed by the proposed method and assay result 
of formulation is shown in Table 12 
CONCLUSION 
The RP-HPLC method for the estimation of TRM, CHL and DIC from 
their combined tablet dosage form was successfully developed. The 
method was validated as per ICH Q2R1 guidelines for Specificity, 
Linearity, Accuracy, Precision, Limit of Detection (LOD), Limit of 
Quantitation (LOQ) and Reproducibility. The method can be 
successfully applied for the routine analysis of the formulation. 
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